Tibet Cheezheng Tibetan Medicine Co Ltd (002287) — Financial Flexibility Index
Tibet Cheezheng Tibetan Medicine Co Ltd (002287) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥76.38 Million (operating CF CN¥34.69 Million minus capex CN¥41.69 Million) represents 0% of total liabilities (CN¥1.78 Billion). Check Tibet Cheezheng Tibetan Medicine Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tibet Cheezheng Tibetan Medicine Co Ltd Financial Flexibility Index (2006–2025)
Historical Financial Flexibility Index trend for Tibet Cheezheng Tibetan Medicine Co Ltd across 20 annual periods. For the full cash flow conversion analysis, see Tibet Cheezheng Tibetan Medicine Co Ltd operating cash flow efficiency.
Annual Financial Flexibility Index for Tibet Cheezheng Tibetan Medicine Co Ltd (2006–2025)
Year-by-year free cash flow to debt coverage for Tibet Cheezheng Tibetan Medicine Co Ltd. Explore cash flow to debt ratio of Tibet Cheezheng Tibetan Medicine Co Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥882.78 Million | CN¥729.70 Million | CN¥1.92 Billion | ▲ +72.8% |
| 2024 | 0.27x | CN¥712.19 Million | CN¥456.75 Million | CN¥2.68 Billion | ▼ -27.5% |
| 2023 | 0.37x | CN¥928.22 Million | CN¥693.41 Million | CN¥2.53 Billion | ▲ +64.4% |
| 2022 | 0.22x | CN¥558.08 Million | CN¥285.69 Million | CN¥2.50 Billion | ▼ -54.8% |
| 2021 | 0.49x | CN¥1.16 Billion | CN¥1.03 Billion | CN¥2.35 Billion | ▲ +56.2% |
| 2020 | 0.32x | CN¥577.62 Million | CN¥238.65 Million | CN¥1.82 Billion | ▼ -50.1% |
| 2019 | 0.63x | CN¥458.22 Million | CN¥405.95 Million | CN¥722.20 Million | ▼ -73.0% |
| 2018 | 2.35x | CN¥628.34 Million | CN¥499.40 Million | CN¥267.54 Million | ▲ +219.6% |
| 2017 | 0.73x | CN¥295.95 Million | CN¥229.83 Million | CN¥402.78 Million | ▼ -58.1% |
| 2016 | 1.75x | CN¥569.08 Million | CN¥389.20 Million | CN¥324.33 Million | ▲ +127.8% |
| 2015 | 0.77x | CN¥322.72 Million | CN¥257.81 Million | CN¥419.05 Million | ▼ -52.5% |
| 2014 | 1.62x | CN¥392.42 Million | CN¥310.95 Million | CN¥242.20 Million | ▼ -48.7% |
| 2013 | 3.16x | CN¥272.86 Million | CN¥198.48 Million | CN¥86.34 Million | ▲ +10.5% |
| 2012 | 2.86x | CN¥231.32 Million | CN¥169.67 Million | CN¥80.90 Million | ▲ +204.0% |
| 2011 | 0.94x | CN¥75.25 Million | CN¥-11.74 Million | CN¥80.01 Million | ▼ -32.5% |
| 2010 | 1.39x | CN¥154.23 Million | CN¥96.91 Million | CN¥110.72 Million | ▲ +10.8% |
| 2009 | 1.26x | CN¥192.02 Million | CN¥175.58 Million | CN¥152.68 Million | ▲ +38.8% |
| 2008 | 0.91x | CN¥89.72 Million | CN¥65.93 Million | CN¥99.02 Million | ▼ -12.0% |
| 2007 | 1.03x | CN¥121.92 Million | CN¥91.43 Million | CN¥118.37 Million | ▲ +164.1% |
| 2006 | 0.39x | CN¥52.40 Million | CN¥38.50 Million | CN¥134.37 Million | — |